USPTO 2025: “Tríade letal” para desafios de validade? O que a guinada política significa para inovadores, investidores e litigantes
Read More<!doctype html> INPI Brazil Modernizes IP Fee Structure to Boost Innovation and Accessibility Brazil’s INPI has implemented a 2025 modernization
Read MoreGet the Full Brazil Pharma IP & BI Report The Brazil Pharma IP & Business Intelligence Report – RPI 2853
Read MoreA Landmark Example of Monitoring in Action In September 2025, the Brazilian Patent and Trademark Office (INPI) published its decision
Read MoreCAS & CAPES ampliam acesso ao CAS BioFinder™ — avanço estratégico para pesquisa e inteligência de patentes no Brasil A
Read More